MUS:CA:TSX- (CAD)

| US Equity |

Last Closing

CAD 49.43

Change

+11.52 (+30.39)%

Market Cap

N/A

Volume

N/A

Analyst Target

N/A
Analyst Rating

N/A

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-09-30 )

Largest Industry Peers for US Equity

Symbol Name Price(Change) Market Cap
VFV:CA Vanguard S&P 500 Index ETF

+0.61 (+0.44%)

CAD 17.23B
ZSP:CA BMO S&P 500

+0.39 (+0.46%)

CAD 16.16B
XSP:CA iShares Core S&P 500 (CAD Hedg..

+0.21 (+0.35%)

CAD 10.90B
VUN:CA Vanguard US Total Market

+0.39 (+0.38%)

CAD 9.56B
XUS:CA iShares Core S&P 500 Index ETF

+0.21 (+0.44%)

CAD 7.36B
HXS:CA Global X S&P 500 Corporate Cla..

+0.39 (+0.49%)

CAD 4.06B
VSP:CA Vanguard S&P 500 CAD hedged

+0.37 (+0.40%)

CAD 3.52B
QUU:CA Mackenzie US Large Cap Equity ..

+0.85 (+0.38%)

CAD 3.25B
XQQ:CA iShares NASDAQ 100 (CAD Hedged..

+0.08 (+0.16%)

CAD 3.07B
XUU:CA iShares Core S&P US Total Mark..

+0.24 (+0.42%)

CAD 3.07B

ETFs Containing MUS:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification (US Equity) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 49.83% N/A N/A N/A N/A
Dividend Return 0.79% N/A N/A N/A N/A
Total Return 50.62% N/A N/A N/A N/A
Trailing 12 Months  
Capital Gain 59.19% N/A N/A N/A N/A
Dividend Return 1.29% N/A N/A N/A N/A
Total Return 60.49% N/A N/A N/A N/A
Trailing 5 Years  
Capital Gain 82.47% N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return 82.47% N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain 5.78% N/A N/A 58% F
Dividend Return 6.70% N/A N/A 56% F
Total Return 0.91% N/A N/A 35% F
Risk Return Profile  
Volatility (Standard Deviation) 12.68% N/A N/A 49% F
Risk Adjusted Return 52.80% N/A N/A 70% C-
Market Capitalization N/A N/A N/A N/A N/A

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike